Technical Analysis for CERS - Cerus Corporation

Grade Last Price % Change Price Change
F 5.57 -1.07% -0.06
CERS closed down 1.07 percent on Wednesday, May 12, 2021, on approximately normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down
Historical CERS trend table...

Date Alert Name Type % Chg
Lower Bollinger Band Walk Weakness 0.00%
Stochastic Reached Oversold Weakness 0.00%
Down 3 Days in a Row Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Below Lower BB Weakness -1.07%
Lower Bollinger Band Touch Weakness -1.07%
Fell Below 20 DMA Bearish -3.63%
Fell Below 50 DMA Bearish -3.63%
MACD Bearish Signal Line Cross Bearish -3.63%
Older End-of-Day Signals for CERS ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
1.5x Volume Pace about 23 hours ago
Down 3% about 23 hours ago
Down 2 % about 23 hours ago
Down 1% about 23 hours ago
Up 1% about 23 hours ago
View Earlier Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Cerus Corporation Description

Cerus Corporation, together with its subsidiary, Cerus Europe B.V., operates as a biomedical products company that focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. The company's INTERCEPT Blood System is based on its proprietary technology for controlling biological replication and is designed to target and inactivate blood-borne pathogens, such as viruses, bacteria, and parasites, as well as potentially harmful white blood cells, while preserving the therapeutic properties of platelet, plasma, and red blood cell transfusion products. Its INTERCEPT Blood System for platelets is designed to inactivate blood-borne pathogens in platelets donated for transfusion; and INTERCEPT Blood System for plasma is designed to inactivate blood-borne pathogens in plasma donated for transfusion. The company is also developing INTERCEPT Blood System for red blood cells, which is designed to inactivate blood-borne pathogens in red blood cells donated for transfusion. It markets its platelet and plasma systems through its direct sales force and distributors primarily in Europe, the Commonwealth of Independent States, and the Middle East. The company has collaboration agreements with Baxter International, Inc. for the development and commercialization of the INTERCEPT Blood System. Cerus Corporation was founded in 1991 and is headquartered in Concord, California.


Sector: Healthcare
Industry: Biotechnology
Keywords: Hematology Proprietary Technology Coronavirus Medical Products Viruses Anatomy Red Blood Cell Blood Concord Transfusion Medicine Blood Cells Platelet Coagulation System Blood Products Blood Transfusion Whole Blood Fusion Products

Is CERS a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 8.87
52 Week Low 5.07
Average Volume 2,229,630
200-Day Moving Average 6.56
50-Day Moving Average 6.05
20-Day Moving Average 5.98
10-Day Moving Average 5.86
Average True Range 0.32
ADX 13.17
+DI 21.41
-DI 27.49
Chandelier Exit (Long, 3 ATRs ) 5.53
Chandelier Exit (Short, 3 ATRs ) 6.36
Upper Bollinger Band 6.39
Lower Bollinger Band 5.56
Percent B (%b) 0.01
BandWidth 13.91
MACD Line -0.11
MACD Signal Line -0.07
MACD Histogram -0.0349
Fundamentals Value
Market Cap 930.98 Million
Num Shares 167 Million
EPS -0.49
Price-to-Earnings (P/E) Ratio -11.32
Price-to-Sales 10.00
Price-to-Book 10.39
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 6.05
Resistance 3 (R3) 6.05 5.88 5.97
Resistance 2 (R2) 5.88 5.76 5.89 5.94
Resistance 1 (R1) 5.73 5.69 5.81 5.73 5.92
Pivot Point 5.56 5.56 5.60 5.57 5.56
Support 1 (S1) 5.41 5.44 5.49 5.41 5.22
Support 2 (S2) 5.24 5.37 5.25 5.20
Support 3 (S3) 5.09 5.24 5.17
Support 4 (S4) 5.09